Jupiter Asset Management Ltd. Buys Shares of 14,824 Globe Life Inc. $GL

Jupiter Asset Management Ltd. purchased a new stake in shares of Globe Life Inc. (NYSE:GL) during the fourth quarter, according to the company in its most recent disclosure with the SEC. The firm purchased 14,824 shares of the company’s stock, valued at approximately $2,073,000.

Other large investors have also recently made changes to their positions in the company. Vanguard Group Inc. raised its holdings in shares of Globe Life by 0.9% during the fourth quarter. Vanguard Group Inc. now owns 10,090,885 shares of the company’s stock valued at $1,411,311,000 after purchasing an additional 86,349 shares during the last quarter. Dimensional Fund Advisors LP boosted its holdings in Globe Life by 2.9% in the third quarter. Dimensional Fund Advisors LP now owns 2,076,232 shares of the company’s stock worth $296,841,000 after purchasing an additional 59,353 shares during the last quarter. AQR Capital Management LLC boosted its holdings in Globe Life by 98.6% in the second quarter. AQR Capital Management LLC now owns 1,402,690 shares of the company’s stock worth $174,340,000 after purchasing an additional 696,548 shares during the last quarter. Pzena Investment Management LLC boosted its holdings in Globe Life by 5.6% in the third quarter. Pzena Investment Management LLC now owns 998,506 shares of the company’s stock worth $142,756,000 after purchasing an additional 52,523 shares during the last quarter. Finally, Swedbank AB boosted its holdings in Globe Life by 15.6% in the fourth quarter. Swedbank AB now owns 962,000 shares of the company’s stock worth $134,545,000 after purchasing an additional 130,000 shares during the last quarter. 81.61% of the stock is currently owned by institutional investors.

Insider Buying and Selling

In other news, CEO James Matthew Darden sold 4,663 shares of Globe Life stock in a transaction dated Tuesday, April 28th. The stock was sold at an average price of $153.88, for a total transaction of $717,542.44. Following the transaction, the chief executive officer directly owned 58,451 shares of the company’s stock, valued at $8,994,439.88. The trade was a 7.39% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, CFO Thomas Peter Kalmbach sold 7,936 shares of Globe Life stock in a transaction dated Friday, May 22nd. The shares were sold at an average price of $156.59, for a total value of $1,242,698.24. Following the transaction, the chief financial officer directly owned 50,496 shares in the company, valued at approximately $7,907,168.64. The trade was a 13.58% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. In the last three months, insiders have sold 124,247 shares of company stock worth $19,040,392. Corporate insiders own 2.11% of the company’s stock.

Globe Life Stock Down 0.2%

GL opened at $153.46 on Friday. The firm’s 50 day simple moving average is $148.85 and its two-hundred day simple moving average is $142.70. The company has a market capitalization of $11.91 billion, a PE ratio of 10.61 and a beta of 0.50. Globe Life Inc. has a 1-year low of $116.73 and a 1-year high of $157.92. The company has a current ratio of 0.07, a quick ratio of 0.07 and a debt-to-equity ratio of 0.38.

Globe Life (NYSE:GL) last issued its quarterly earnings data on Wednesday, April 22nd. The company reported $3.43 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $3.46 by ($0.03). The business had revenue of $1.56 billion for the quarter, compared to the consensus estimate of $1.56 billion. Globe Life had a net margin of 19.38% and a return on equity of 20.94%. The company’s revenue was up 5.3% on a year-over-year basis. During the same period in the previous year, the firm earned $3.07 EPS. Globe Life has set its FY 2026 guidance at 15.400-15.90 EPS. As a group, equities analysts forecast that Globe Life Inc. will post 15.62 EPS for the current year.

Globe Life Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Friday, July 31st. Shareholders of record on Monday, July 6th will be issued a dividend of $0.33 per share. This represents a $1.32 annualized dividend and a yield of 0.9%. The ex-dividend date of this dividend is Monday, July 6th. Globe Life’s payout ratio is currently 9.13%.

Analyst Upgrades and Downgrades

GL has been the topic of several research reports. Wells Fargo & Company raised their target price on shares of Globe Life from $171.00 to $172.00 and gave the stock an “overweight” rating in a report on Friday, April 10th. Evercore set a $157.00 price target on Globe Life in a research note on Wednesday, February 18th. Texas Capital upgraded Globe Life to a “strong-buy” rating in a research note on Wednesday, March 18th. Weiss Ratings upgraded Globe Life from a “buy (b-)” rating to a “buy (b)” rating in a research note on Wednesday, May 13th. Finally, Morgan Stanley raised their price target on Globe Life from $176.00 to $181.00 and gave the stock an “overweight” rating in a research note on Thursday, May 21st. One investment analyst has rated the stock with a Strong Buy rating, eight have assigned a Buy rating and two have issued a Hold rating to the company. Based on data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and an average price target of $174.11.

Globe Life Company Profile

Globe Life, traded on the NYSE under the symbol GL, is a U.S.-based insurance holding company that underwrites and distributes a range of life and supplemental health insurance products. Through its subsidiary brands—Globe Life, American Income Life, Liberty National Life, United American Insurance Company and Family Heritage Life—it offers term life, whole life, fixed annuities and supplemental health coverage designed to meet the needs of individuals and families across various socioeconomic segments.

The company’s product suite includes low-cost, easy-to-understand life insurance policies, accidental death and dismemberment coverage, hospital indemnity plans and specified disease insurance.